The effect of fenoprofen calcium (Nalfon) on levels of rheumatoid factor in patients with rheumatoid arthritis.
In 88.9% of a group of 18 patients with rheumatoid arthritis participating in an open-label study with fenoprofen calcium (Nalfon), there was observed a mean titre decrease in level of rheumatoid factor as compared to baseline levels. In follow-up, three months to one year later, a uniform titre increase above the mean level of the study period had occurred. In all cases the titre returned to baseline levels or higher.
D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002118:Calcium / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004341:Drug Evaluation; D005279:Fenoprofen / Q000627:therapeutic use*; D006046:Gold / Q000627:therapeutic use; D006801:Humans; D010666:Phenylpropionates / Q000627:therapeutic use*; D012217:Rheumatoid Factor / Q000032:analysis*
D010666:Phenylpropionates; D006046:Gold; D012217:Rheumatoid Factor; D005279:Fenoprofen; D002118:Calcium